1. Home
  2. SCNX vs FGEN Comparison

SCNX vs FGEN Comparison

Compare SCNX & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNX
  • FGEN
  • Stock Information
  • Founded
  • SCNX 2010
  • FGEN 1993
  • Country
  • SCNX United States
  • FGEN United States
  • Employees
  • SCNX N/A
  • FGEN N/A
  • Industry
  • SCNX Other Pharmaceuticals
  • FGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCNX Health Care
  • FGEN Health Care
  • Exchange
  • SCNX Nasdaq
  • FGEN Nasdaq
  • Market Cap
  • SCNX 33.6M
  • FGEN 34.5M
  • IPO Year
  • SCNX 2020
  • FGEN 2014
  • Fundamental
  • Price
  • SCNX $3.17
  • FGEN $0.52
  • Analyst Decision
  • SCNX
  • FGEN
  • Analyst Count
  • SCNX 0
  • FGEN 0
  • Target Price
  • SCNX N/A
  • FGEN N/A
  • AVG Volume (30 Days)
  • SCNX 12.0K
  • FGEN 709.3K
  • Earning Date
  • SCNX 02-25-2025
  • FGEN 02-24-2025
  • Dividend Yield
  • SCNX N/A
  • FGEN N/A
  • EPS Growth
  • SCNX N/A
  • FGEN N/A
  • EPS
  • SCNX 3.55
  • FGEN N/A
  • Revenue
  • SCNX N/A
  • FGEN $180,015,000.00
  • Revenue This Year
  • SCNX $1,085.75
  • FGEN $21.91
  • Revenue Next Year
  • SCNX N/A
  • FGEN N/A
  • P/E Ratio
  • SCNX $1.31
  • FGEN N/A
  • Revenue Growth
  • SCNX 166.67
  • FGEN 16.15
  • 52 Week Low
  • SCNX $3.01
  • FGEN $0.18
  • 52 Week High
  • SCNX $44.56
  • FGEN $2.80
  • Technical
  • Relative Strength Index (RSI)
  • SCNX N/A
  • FGEN 53.72
  • Support Level
  • SCNX N/A
  • FGEN $0.46
  • Resistance Level
  • SCNX N/A
  • FGEN $0.51
  • Average True Range (ATR)
  • SCNX 0.00
  • FGEN 0.04
  • MACD
  • SCNX 0.00
  • FGEN -0.00
  • Stochastic Oscillator
  • SCNX 0.00
  • FGEN 78.67

About SCNX Scienture Holdings Inc. Common Stock

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Share on Social Networks: